Effects of the presence of ColE1 plasmid DNA in Escherichia coli on the host cell metabolism by Wang, Zhijun et al.
BioMed  Central
Page 1 of 18
(page number not for citation purposes)
Microbial Cell Factories
Open Access Research
Effects of the presence of ColE1 plasmid DNA in Escherichia coli on 
the host cell metabolism
Zhijun Wang1,2, Li Xiang1, Junjie Shao1, Alicja Węgrzyn3 and 
Grzegorz Węgrzyn*4,5
Address: 1Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, 200032, Shanghai, People's Republic of 
China, 2Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, 14853, NY, USA, 
3Laboratory of Molecular Biology (affiliated with the University of Gdańsk), Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 
Kładki 24, 80-822 Gdańsk, Poland, 4Department of Molecular Biology, University of Gdańsk, Kładki 24, 80-822 Gdańsk, Poland and 5Department 
of Genetics and Marine Biotechnology, Institute of Oceanology, Polish Academy of Sciences, Św. Wojciecha 5, 81-347 Gdynia, Poland
Email: Zhijun Wang - zjwang@shmu.edu.cn; Li Xiang - xiangli56318@sina.com; Junjie Shao - shaojunjie76034@sina.com; 
Alicja Węgrzyn - alawegrzyn@yahoo.com; Grzegorz Węgrzyn* - wegrzyn@biotech.univ.gda.pl
* Corresponding author    
Abstract
Background: Although understanding of physiological interactions between plasmid DNA and its
host is important for vector design and host optimization in many biotechnological applications, to
our knowledge, global studies on plasmid-host interactions have not been performed to date even
for well-characterized plasmids.
Results: Escherichia coli cells, either devoid of plasmid DNA or bearing plasmid pOri1 (with a single
ColE1 replication origin) or plasmid pOri2 (with double ColE1 replication origins), were cultured
in a chemostat. We used a combination of metabolic flux analysis, DNA microarray and enzyme
activity analysis methods to explore differences in the metabolism between these strains. We found
that the presence of plasmids significantly influenced various metabolic pathways in the host cells,
e.g. glycolysis, the tricarboxylic acid (TCA) cycle and the pentose phosphate (PP) pathway.
Expression of rpiA, a gene coding for ribose-5-phosphate isomerase A, was considerably decreased
in E. coli carrying a high copy number plasmid relative to E. coli carrying a low copy number plasmid
and plasmid-free E. coli. The rpiA gene was cloned into an expression vector to construct plasmid
pETrpiA. Following induction of pETrpiA-bearing E. coli, which harbored either pOri1 or pOri2,
with isopropyl-β-D-thiogalactopyranoside (IPTG), the copy number of pOri1 and pOri2 was
sigificantly higher than that measured in a host devoid of pETrpiA.
Conclusion: The presence of plasmids can significantly influence some metabolic pathways in the
host cell. We believe that the results of detailed metabolic analysis may be useful in optimizing host
strains, vectors and cultivation conditions for various biotechnological purposes.
Background
Plasmids are among the most widely used model repli-
cons and tools in molecular biology and biotechnology.
However, only a few reports were published to-date about
the effects of plasmid DNA on the metabolism of
Escherichia coli [1-3]. On the other hand, an optimization
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of plasmid vectors and host strains has received an impor-
tant interest in biotechnology, especially due to findng
novel applications of plasmids, like gene therapy and
development of DNA vaccines [1,4,5]. Undoubtedly,
understanding physiological interactions between plas-
mid DNA and its host is important for vector design and
host optimization [1,3,6,7].
The presence of plasmid DNA can have various impacts
on the host physiology, including perturbation in DNA
replication, transcription and translation [8]. Effects of
plasmids on the E. coli metabolism were investigated, and
it was found that the presence of plasmid DNA caused an
increase in glucose uptake rate, and revealed faster drop of
the extracellular and intracellular pH and higher accumu-
lation of lactic, acetic, formic, and succinic acids [9]. A
hypothesis was presented that plasmids influence host
metabolism through changes in the cAMP-binding pro-
tein (cAMP)-CRP complex, which in turn causes the sub-
stantial alteration in the regulatory status of the glucose
uptake rate [8]. Effects of plasmid DNA on the growth rate
of host cells were also reported. For example it was found
that the growth rate of E. coli strain DH1 containing plas-
mid pGSK001 decreased from 0.63 h-1 to 0.55 h-1 [6], and
similar conclusions on the effects of plasmids on bacterial
growth were reported by other authors [8].
Birnbaum and Bailey demonstrated that the presence of
plasmids in E. coli HB101 induced an increase in levels of
enzymes involved in the tricarboxylic acids cycle, ribos-
ome assembly, protein biosynthesis and the heat shock
response. Moreover, they observed that PEP carboxylase
and succinate dehydrogenase were among the proteins
whose levels were higher in the presence of plasmids [10].
Rozkov et al. [6] has proposed that plasmids can influence
cell metabolism through increasing ATP synthesis, neces-
sary for expression of an antibiotic-resistance gene.
In spite of some work pefromed previously (see above), to
our knowledge, global studies on plasmid-host interac-
tions have not been performed to-date even for well-char-
acterized plasmids. It encouraged us to analyse the impact
of plasmid DNA on the metabolism of E. coli host using
methods of the 13C flux technology, DNA microarray and
enzyme activity analysis.
Metabolic flux analysis is important in characterizing cel-
lular phenotypes [11]. The proteinogenic amino acids
serve as valuable probes to study glycolysis, metabolism
of pyruvate, the pentose phosphate (PP) pathway and the
tricarboxylic acid (TCA) cycle. Mixtures of [U-13C]glucose
and unlabelled glucose are useful to resolve fluxes down-
stream of PEP. An exclusive use of [1-13C]glucose is valu-
able for resolving the upper part of the metabolism, close
to the PP pathway. Direct analytical interpretation of 13C-
labelling patterns has been used sucessfully in biochemi-
cal research. More recently, analytical interpretation of the
13C-labelling pattern in proteinogenic amino acids was
developed, and several flux partition ratios can be quanti-
fied in a single experiment [12,13]. Net fluxes through
metabolic networks can be obtained from 13C-labelling
information, when combined with material balance
within a stoichiometric model [12,14,15]. DNA microar-
rays have been intensively used to explore the response of
wild-type E. coli gene expression to a variety of environ-
mental conditions, for example, acetate [16], oxygen
availability [17], biofilm formation [18], and protein
overproduction [19-21]. Furthermore, enzyme activity
analysis has been considered an important method to
analyse the metabolism of microorganism [22,23].
Because ColE1-like plasmids belong to the best character-
ized replicons and the most intensively used plasmids in
biotechnology, such replicons were selected as models to
investigate plasmid effects on the E. coli metabolism.
Results
Bacterial growth
Two ColE1-derived plasmids were constructed, which
bear either a single ColE1 origin region (pOri1) or two
such regions (pOri2). This pair of plasmids was used,
instead of other well-characterized low- and high-copy
number plasmids, to avoid any unpredictable effects of
metabolic differences caused by various types of replicons
(the only considerable difference between pOri1 and
pOri2 is the number of replication origins; see Fig. 1). To
analyse the metabolic differences between E. coli strains
BL21, BL21/pOri1 and BL21/pOri2, batch cultures were
performed in 5 l fermentor BIOSTAT® B-DCU with the
working volume of 2 l. The growth rates of BL21, BL21/
pOri1 and BL21/pOri2 were compared during bath culti-
vation at 16 h in the early stationary phase. The growth
rates of these strains were 0.46 h-1, 0.39 h-1 and 0.29 h-1,
respectively. The growth rate of BL21 carrying a high copy
number plasmid pOri2 was significantly lower than that
of BL21 carrying a low copy number plasmid pOri1. These
results are compatible with previous observations.
Although low copy number plasmids have a minor contri-
bution to total cellular biomass, DNA amount of high
copy number plasmids in a host cell may be considerable
in comparison to chromosomal DNA. Thus, one migh
speculate that plasmids may cause significant effects on
the growth characteristics of E. coli. To analyse effects of
plasmid DNA on the metabolism of E. coli, the chemostat
cultures were performed to obtain steady state cultivation
under of the growth rates of 0.46 h-1 for BL21, 0.39 h-1 for
BL21/pOri1 and 0.29 h-1 for BL21/pOri2, with feeding a
complete culture medium. The growth rates were identical
to those measured when these three strains were culturedMicrobial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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for 16 h in the batch cultivation. The growth characteris-
tics of E. coli are shown in Table 1. Plasmid pOri1 copy
number in BL21 was estimated to about 50, however the
plasmid pOri2 copy number in this strain was about 400.
As pOri1 and pOri2 are a pair of otherwise identical plas-
mids bearing one or two origin regions, respectively, we
suggest that the significantly increased plasmid DNA copy
number in BL21/pOri2 was probably caused by the pres-
ence of two origins of replication in this plasmid.
The expenditure of glucose in BL21, BL21/pOri1 and
BL21/pOri2 was 5.2, 7.0 and 6.3 mmol g-1 h-1, respectively
(Table 1). Surprisingly, the expenditure of glucose in
BL21/pOri2 was lower than that in BL21/pOri1. Thus, the
presence of plasmid DNA pOri1 can significantly improve
the glucose expenditure relative to plasmid-free E. coli
BL21, however the BL21 carrying a high copy number
plasmid pOri2 does not increase the expenditure of glu-
cose in comparison to BL21 carrying a low copy number
plasmid pOri1. This might be due to the lower early sta-
tionary phase growth rate of BL21/pOri2 than BL21/
pOri1.
Acetate secretion was low in BL21, however significantly
higher acetate secretion was found in BL21/pOri1 (4.1
mmol g-1 h-1) and BL21/pOri2 (4.4 mmol g-1 h-1) (Table
1). Oxygen uptake rates were increased in plasmid-con-
taining strains over those of the plasmid-free strain (Table
1). Our results indicated that E. coli BL21 carrying a high
copy number plasmid pOri2 did not increase the oxygen
uptake relative to E. coli BL21 carrying a low copy number
plasmid pOri1. Similar correlations were obtained when
CO2 secretion was measured (Table 1). In summary, the
high copy number plasmid pOri2 in E. coli BL21 induced
lower growth rates, and higher acetate secretion than the
low copy number plasmid pOri1. The presence of plasmid
pOri1 or pOri2 can significantly decrease the growth rate,
and increase the O2 and glucose uptake rates relative to
plasmid-free E. coli BL21.
Although we have controlled the growth rate of E. coli, it
has been found that growth rates can affect the growth
characteristic of E. coli [24]. To analyse the effects of
ColE1-like plasmids on the growth characteristics of E.
coli, strains BL21, BL21/pOri1 and BL21/pOri2 were cul-
tured at the same growth rate (0.2 h-1) in the chemostat
system. The growth characteristics are shown in Table 2.
The expenditure of glucose in BL21, BL21/pOri1 and
BL21/pOri2 was 2.6, 4.8 and 5.7 mmol (g biomass)-1 h-1,
respectively. The Biomass yield rate of BL21, BL21/pOri1
and BL21/pOri2 was 0.161 g h-1, 0.261 g h-1 and 0.207 g
h-1, respectively. However, the plasmid DNA copy
number in BL21, BL21/pOri1 and BL21/pOri2 (Table 2)
did not change significantly relatively to experiments
shown in Table 1.
Enzyme activity analysis
Some key enzymes of central metabolism were assayed
during the early stationary phase and at the same growth
rate. Activities of 26 enzymes involved in the central met-
abolic pathways of E. coli BL21, BL21/pOri1, BL21/pOri2
during the early stationary phase and at the same growth
rate are shown in Table 3 and Table 4.
Activities of the glycolysis pathway enzymes, such as:
HEK, GPI, PFK, FBP, FBA, GPD, TPI, PPC and PK, were
increased in BL21/pOri1 and BL21/pOri2 relative to BL21
at the early stationary phase and at the same growth rate
(Tables 3 and 4). There were no significant differences in
activities of glycolysis enzymes' activities between BL21/
pOri1 and BL21/pOri2 at the early stationary phase,
although there were some increases of HEK, PFK, FBP,
FBA, GPD and PCC activities at the same growth rate
(Table 4). In summary, our results show that E. coli BL21
containing a high copy number plasmid pOri2 does not
reveal significantly increased glycolysis enzymes' activities
in comparison to the E. coli BL21 containing a low copy
number plasmid pOri1 (Tables 3 and 4).
PP pathway enzymes, such as: GPDH, PGL, PGD, RPE,
RPI, TK and TA were down-regulated in the BL21/pOri1 or
BL21/pOri2 relative to BL21 at the early stationary phase
and the same growth rate (Tables 3 and 4), and the PP
pathway enzyme activities of BL21/pOri2 were lower than
those of BL21/pOri1 (Tables 3 and 4). RPI was the most
significantly down-regulated enzyme in the PP pathway in
BL21/pOri2 at the early stationary phase and the same
growth rate (Tables 3 and 4). Our results showed that E.
coli  BL21 carrying a high copy number plasmid pOri2
revealed lower PP pathway enzyme activities than E. coli
BL21 carrying a low copy number plasmid pOri1 at the
early stationary phase and the same growth rate (Tables 3
and 4).
Tricarboxylic acid (TCA) cycle enzymes, such as: CS, ICD,
ICL, AH, OGD, SD, FH and MD revealed significantly
increased activities in BL21/pOri1 and BL21/pOri2 rela-
tive to BL21 at the early stationary phase (Table 3) and at
the same growth rate (Table 4). There were no significant
differences in the TCA enzyme activities between BL21/
pOri1 and BL21/pOri2 during the early stationary phase
(Table 3). These results are in correlation with the higher
glucose use and oxygen uptake rate of the BL21/pOri1 and
BL21/pOri2 than BL21 (Table 1). Moreover, there were no
significant differences in the MAC and PCK enzyme activ-
ities among BL21, BL21/pOri1 and BL21/pOri2 (Table 3
and 4).
Metabolic flux analysis
The metabolic fluxes of BL21/pOri1 and BL21/pOri2 at
early stationary phase and the same growth rate wereMicrobial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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directly compared with those of BL21. We found that pro-
tein and lipid contents of BL21/pOri2 (μ = 0.29 h-1) and
BL21/pOri1 (μ = 0.39 h-1) were lower than those of BL21
(μ = 0.46 h-1), however the RNA contents of BL21/pOri2
and BL21/pOri1 were higher than those of BL21 at the
early stationary phase (Table 5). The cellular ingredients
of protein, lipid, RNA, and LPS in BL21, BL21/pOri1 and
BL21/pOri2 were determined as constant at the same
growth rate (μ = 0.2 h-1) except plasmid DNA compo-
nents. Table 6 shows the ingredients of protein, DNA and
RNA in BL21, BL21/pOri1 and BL21/pOri2 at different
growth rates. Ingredients of amino acids, nucleotides in
BL21, BL21/pOri1 and BL21/pOri2 were different during
the early stationary phase, however, the ingredients of
amino acids and nucleotides were constant at the same
growth rate (Table 6).
Construction of two ColE1-derived plasmids, pOri1 (2,811 bp) and pOri2 (4,575 bp) Figure 1
Construction of two ColE1-derived plasmids, pOri1 (2,811 bp) and pOri2 (4,575 bp). The construction was performed as fol-
lows: (A): ColE1 replication origin was amplified from ColE1 plasmid DNA with the indicated primers (white arrow in Fig. 1A). 
The PCR amplified origin fragment was used for construction of pOri1; (B): The PCR product from step A was linked with an 
ampicillin-resistance gene to construct a new plasmid pOri1. The whole pOri1 plasmid DNA was amplified with the indicated 
primer (white arrow in Fig. 1B). The PCR amplified whole pOri1 was used for the construction of pOri2; (C): The PCR ampli-
fied whole pOri1 product was linked with ColE1 replication origin fragment from step A again to construct a new plasmid 
pOri2.
Table 1: Growth parameters of E. coli strains BL21, BL21/pOri1 and BL21/pOri2 cultured in the chemostat system at different growth 
rates.
Parametera Value
BL21 BL21/pOri1 BL21/pOri2
QGluc 10.96 35.00 36.01
μ 0.46 0.39 0.29
qGluc 5.04 13.65 10.46
Ybiomass 0.97 1.95 1.66
ybiomass 0.45 0.76 0.48
rGluc 5.2 7.0 6.3
rAce 0 4.1 4.4
rO2 11.0 16.9 16.5
rCO2 12.2 17.9 17.3
Plas. copies 0 50 410
a The following growth rates were determined when bacteria were cultured for 16 h in the batch cultivation: BL21, 0.46 h-1; BL21/pOri1, 0.39 h-1; 
BL21/pOri2, 0.29 h-1. Abbreviations: QGluc (mmol), Glucose consumption amount; μ (h-1), growth rate; qGluc (mmol h-1), Glucose consumption rate; 
Ybiomass (g), Biomass yield; ybiomass (g h-1), Biomass yield rate; rGluc (mmol g-1 h-1), Glucose consumption rate per biomass; rAce (mmol g-1 h-1), Acetate 
yield per biomass; rO2 (mmol g-1 h-1), Oxygen uptake rates per biomass; rCO2 (mmol g-1 h-1), CO2 secretion per biomass; Plas. copies, Plasmid copy 
numberMicrobial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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Table 2: Growth parameters of E. coli strains BL21, BL21/pOri1 and BL21/pOri2 cultured in the chemostat system at the same growth 
rate.
Parametera Value
BL21 BL21/pOri1 BL21/pOri2
QGluc 10.4 24.8 29.45
μ 0.20 0.20 0.20
qGluc 2.08 4.96 5.89
Ybiomass 0.805 1.305 1.035
ybiomass 0.161 0.261 0.207
rGluc 2.6 4.8 5.7
rAce 0.5 2.4 5.5
rO2 7.3 13.1 13.8
rCO2 7.7 13.8 14.4
Plas. copies 0 80 420
a The growth rate of each culture was 0.2 h-1. The abbreviations are as described in Table 1.
Table 3: Specific enzyme activities in E. coli strains BL21, BL21/pOri1 and BL21/pOri2 cultured in the chemostat system at different 
growth rates.
Enzymea Activity (μmol min-1 mg-1)b,c
BL21 BL21/pOri1 BL21/pOri2
HEK 0.030 0.100 0.110
GPI 2.290 4.660 4.630
PFK 0.240 0.640 0.600
FBP 0.014 0.043 0.049
FBA 1.210 2.960 2.810
GPD 0.026 0.051 0.052
TPI 1.700 4.400 4.410
PPC 0.220 0.430 0.440
PK 0.044 0.098 0.102
GPDH 0.350 0.120 0.070
PGL 0.280 0.210 0.120
PGD 0.150 0.090 0.080
RPE 0.320 0.150 0.100
RPI 0.540 0.230 0.030
TK 0.080 0.010 0.005
TA 0.120 0.070 0.020
CS 0.021 0.086 0.082
ICD 0.150 0.840 0.830
ICL 0.013 0.046 0.045
AH 0.090 0.190 0.210
OGD 0.022 0.088 0.810
SD 0.020 0.090 0.110
FH 0.021 0.097 0.110
MD 0.046 0.094 0.101
MAC 0.002 0.004 0.003
PCK 0.002 0.003 0.003
a Abbreviations: HEK, Hexokinase; GPI, Glucose-6-phosphate isomerase; PFK, 6-phosphofructosekinase; FBP, Fructose-1,6-bisphosphatase; FBA, 
Fructose-bisphosphate aldolase; GPD, Glyceraldehyde-3-phosphate dehydrogenase; TPI, Triose phosphate isomerase; PPC, Phosphoenolpyruvate 
carboxylase; PK, Pyruvate kinase; GPDH, Glucose-6-phosphate dehydrogenase; PGL, 6-Phosphogluconolactonase; PGD, Phosphogluconate 
dehydrogenase; RPE, Ribulose-phosphate 3-epimerase; RPI, Ribose-5-phosphate isomerase; TK, Transketolase; TA, Transaldolase; CS, Citrate 
synthase; ICD, NADP+-specific isocitrate dehydrogenase; ICL, Isocitrate lyase; AH, Aconitate hydratase; OGD, Oxoglutarate dehydrogenase; SD, 
Succinic semialdehyde dehydrogenase; FH, Fumarate hydratase; MD, Malate dehydrogenase; MAC, Malic enzyme; PCK, Phosphoenolpyruvate 
carboxykinase.
b The following growth rates were determined when bacteria were cultured in the batch cultivation: BL21, 0.46 h-1; BL21/pOri1, 0.39 h-1; BL21/
pOri2, 0.29 h-1.
c The experiments were performed in triplicate and the results are shown as the average of three measurements with the standard deviation less 
than 5%.Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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To determine the metabolic fluxes of E. coli carrying differ-
ent copy number plasmids, we performed the 13C glucose
labelled experiments, in which the metabolic ratios of sev-
eral metabolic nods were determined. The metabolic flux
ratios of intracellular metabolites of BL21, BL21/pOri1
and BL21/pOri2 were analysed with the FiatFlux 1.0 soft-
ware [25]. The metabolic flux ratio results at different
growth rate are shown in Fig. 2A and 2B.
The final distributions of metabolic fluxes in strains BL21,
BL21/pOri1 and BL21/pOri2 were determined with Flux-
Analyzer 5.1 software [26]. The metabolic fluxes of BL21,
BL21/pOri1, BL21/pOri2 at the early stationary phase are
shown in Fig. 3A, and those at the same growth rate are
shown in Fig. 3B.
Glycolysis starts from glucose, and leads to pyruvate as its
final product [27]. From the metabolic flux analysis, the
levels of glycolytic intermediates, such as G6P, F6P, F1,6P,
G3P, PGP, 3PG, 2PG, PEP and Pyr were significantly
increased in the BL21/pOri1 and BL21/pOri2 relative to
BL21 during the early stationary phase (Fig. 3A).
A quantitative description of the relative fluxes is impor-
tant in the analysis of the PP pathway and glycolysis path-
way. During the early stationary phase, the fluxes of
6PGlac in BL21, BL21/pOri1 and BL21/pOri2 were deter-
mined as 3.275, 1.769 and 0.729 mmol g-1 h-1, respec-
tively (Fig. 3A). The 6PGlac flux of BL21/pOri1 decreased
to 54.01 % of that estimated in BL21, and the 6PGlac flux
of BL21/pOri2 decreased to 41.20 % of that estimated in
BL21/pOri1. During the early stationary phase, leveles of
PP pathway intermediates, such as 6PGlac, 6PG, Ru5P,
X5P, R5P, E4P, S7P were significantly decreased in BL21/
pOri1 and BL21/pOri2 relative to BL21 (Fig. 3A). As for
the BL21/pOri2 strain, the PP pathway represented
11.54% of the glycolysis pathway flux (6PGlac from
G6P), versus 25.09% for BL21/pOri1 metabolism, while
the PP flux for BL21 was determined to be 63.27% of the
glycolysis flux (Fig 2A). The flux ratio of F6P from G6P
was increased in BL21/pOri1 and BL21/pOri2 relative to
BL21, however, the flux ratio of F6P from X5P or X7P was
decreased in plasmid-carrying E. coli relative to plasmid-
free E. coli (Fig 2A). The flux ratios of OxA from PEP, PEP
from OxA, Pyr from Mal, and Mal from Glyox were
Table 4: Specific enzyme activities in BL21, BL21/pOri1 and BL21/pOri2 strains grown in the chemostat system at the same growth 
rate.
Enzymea Activity (μmol min-1 mg-1)b
BL21 BL21/pOri1 BL21/pOri2
HEK 0.012 0.051 0.074
GPI 0.947 2.228 2.085
PFK 0.104 0.241 0.311
FBP 0.004 0.020 0.034
FBA 0.402 1.439 1.937
GPD 0.011 0.023 0.034
TPI 0.719 1.991 2.072
PPC 0.093 0.129 0.253
PK 0.017 0.047 0.043
GPDH 0.108 0.061 0.036
PGL 0.103 0.090 0.058
PGD 0.038 0.040 0.043
RPE 0.107 0.073 0.059
RPI 0.180 0.096 0.013
TK 0.033 0.003 0.003
TA 0.037 0.035 0.014
CS 0.007 0.040 0.055
ICD 0.064 0.361 0.404
ICL 0.005 0.022 0.021
AH 0.030 0.085 0.097
OGD 0.006 0.031 0.369
SD 0.006 0.044 0.067
FH 0.008 0.035 0.069
MD 0.018 0.043 0.065
MAC 0.001 0.001 0.002
PCK 0.001 0.001 0.002
a Abbreviations are as described in the footnote to Table 3.
b The growth rate of each culture was 0.2 h-1. The experiments were performed in triplicate and the results are shown as the average of three 
measurements with the standard deviation less than 5%.Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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decreased in BL21/pOri2 or BL21/pOri1 relative to in
BL21 (Fig 2A).
During the early stationary phase, the flux ratio of Mal
from Glyox derived from the glyoxylate cycle was signifi-
cantly decreased in BL21/pOri1 or BL21/pOri2 relative to
BL21 (Fig. 3A), and the flux ratio of ICit toward α-KG was
increased in BL21/pOri1 and BL21/pOri2 in comparison
to ICit toward α-KG in BL21 (Fig. 3A). The α-KG contrib-
uted an important flux for the synthesis of amino acid and
nucleotides.
The BL21/pOri1 revealed an increase in Cit in TCA cycle
flux by 36.9% (from 2.845 mmol g-1 h-1 in BL21 to 3.879
mmol g-1 h-1 in BL21/pOri1) (Fig. 3A). However the pres-
ence of BL21/pOri2 had a minor effect on this paramenter
relative to BL21/pOri1 (Fig. 3A). Thus, E. coli BL21 carry-
ing a high copy number plasmid pOri2 did not signifi-
cantly influence the TCA cycle relative to the host bearing
the low copy number plasmid pOri1 (Fig. 3A).
It was demonstrated previously that malic enzyme plays a
central role in increasing levels of lipids [28]. Malic
enzyme catalyses converting Mal to Pyr, and it is NADP+
dependent [29]. The presence of flux from Mal to Pyr can
be determined by comparison of labeling of the C-1 and
C-2 carbon atoms of Pyr with those of PEP [30]. In our
experiments, during the early stationary phase, the meta-
bolic flux from Mal to Pyr decreased significantly from 0.4
mmol g-1 h-1 in BL21, to 0.01 mmol g-1 h-1 in BL21/pOri2.
However, similar malic enzyme activities were found in
BL21/pOri2, BL21/pOri1 and BL21 (Table 3). This can be
explained by a significant decrease in the glyoxyate cycle
fluxes. The flux from ICit to Glyox decreased from 0.844
mmol g-1 h-1 in BL21 to 0.053 mmol g-1 h-1 in BL21/pOri2
(Fig. 3A). It has been found that malic enzyme activity was
high under conditions favourable for lipid accumulation
[29]. Our results show that BL21 carrying high copy
number plasmid pOri2 did not reveal an increase in lipid
accumulation relative to BL21 carrying a low copy
number plasmid pOri1 (Table 5).
From the metabolic flux analysis, during the early station-
ary phase, the ATP production and expenditure in BL21
were 27.86 mmol g-1 h-1, and 15.28 mmol g-1 h-1, respec-
tively (Fig. 3A). Thus, it appears that ATP should not be a
limiting factor in BL21. However, in BL21/pOri2, the ATP
production and expenditure were 41.55 mmol g-1 h-1and
42.28 mmol g-1 h-1, respectively (Fig. 3A). Hence, ATP was
one of the limiting factors in BL21 carrying a high copy
number plasmid pOri2. From the metabolic flux analysis
during the early stationary phase, the uptake fluxes of SO4
2- and NH4 
+ were decreased in BL21/pOri1 and BL21/
pOri2 relative to BL21 (Fig. 3A), possibly because E. coli
cells carrying plasmid revealed lower growth rates than
plamid-free E. coli cells.
From our experimental results, it appears that during the
early stationary phase, the PP pathway was one of the
important limiting factors of E. coli BL21 containing a
high copy number plasmid, while the TCA pathway was
not a limiting factor for E. coli BL21 containing a high
copy number plasmid relative to a low copy number plas-
mid.
To determine the effects of growth rates on the metabolic
flux analysis, we continuously cultured BL21, BL21/
pOri1, BL21/pOri2 under the same growth rates as 0.2 h-
Table 5: Cellular components of E. coli strains BL21, BL21/pOri1 and BL21/pOri2 cultured in the chemostat system at different growth 
rates.
Component Biomass g (g biomass)-1
Various growth ratesa 0.2 h-1
BL21 BL21/pOri1 BL21/pOri2 All strains
Protein 0.620 0.615 0.611 0.610
Lipid 0.119 0.109 0.102 0.102
RNA 0.185 0.200 0.205 0.211
Chromosomal DNA 0.031 0.031 0.031 0.031
Plasmid 0 0.0002 0.0019 b
LPS 0.015 0.015 0.015 0.015
Peptidoglycan 0.015 0.015 0.015 0.015
Glycogen 0.015 0.015 0.015 0.015
a The following growth rates were determined when bacteria were cultured in the batch cultivation: BL21, 0.46 h-1; BL21/pOri1, 0.39 h-1; BL21/
pOri2, 0.29 h-1.
b Plasmid DNA concentrations in BL21, BL21/pOri1, and BL21/pOri2 were 0, 0.0004, and 0.0020 g (g biomass)-1, respectively.Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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1. The metabolic flux analysis results are shown in Fig. 3B.
Surprisingly, TCA flux in the high copy number plasmid
carrying E. coli BL21/pOri2 was lower than in the case of
low copy number plasmid BL21/pOri1. Thus, TCA was
one of limiting factors for plasmid DNA replication at the
relatively low growth rate 0.2 h-1 (Fig. 3B). Several key
fluxes in the PP pathway in the high copy number plas-
mid-carrying E. coli BL21/pOri1 were higher than in the
low copy number plasmid-carrying E. coli BL21/pOri2
(Fig. 3B) except the flux from Ru5P to R5P. These results
indicate that the fluxes from Ru5P to R5P might be limit-
ing factors for ColE1-like plasmid DNA replication. More-
over, ATP was not a limiting factor for plasmid DNA
replication when BL21/pOri2 was cultured at relatively
lower growth rate 0.2 h-1 (Fig. 3B).
In summary, from the metabolic flux analysis of E. coli
BL21/pOri1, BL21/pOri2 at the early stationary phase and
at the same growth rate, presented in the report, one may
conclude that the flux from Ru5P to R5P is the important
limiting factor for ColE1-like plasmid DNA replication.
Effects of plasmids on E. coli gene expression
Transcription profiles in BL21, BL21/pOri1 and BL21/
pOri2 were analysed using DNA microarray technology.
The strains were cultured in a chemostat and harvested
after the cultivation reached the steady status. Total RNA
was isolated and transcripts were reverse-transcribed into
cDNAs. The RNAs from the BL21, BL21/pOri1, BL21/
pOri2 were labelled with biotin.
The labelled cDNAs were mixed and then hybridized on
the microarray slides. Experiments were repeated four
times. Expression datasets have been deposited in the
Gene Expression Omnibus database [GEO:GSE5239].
Over 3100 genes were successfully detected in the DNA
microarray experiments. Most of them revealed no signif-
Table 6: Levels of amino acids and nucleotides in E. coli strains BL21, BL21/pOri1 and BL21/pOri2 cultured in the chemostat system at 
different growth rates.
Biomass (mmol g-1)
Component Various growth ratesa 0.2 h-1
BL21 BL21/pOri1 BL21/pOri2 All strains
Ala 0.940 0.976 0.995 0.996
Arg 0.465 0.511 0.529 0.531
Asp 0.620 0.465 0.438 0.43
Asn 0.465 0.474 0.474 0.474
Cys 0.146 0.146 0.146 0.146
Glu 0.520 0.529 0.538 0.539
Gln 0.566 0.438 0.374 0.373
Gly 0.849 0.411 0.319 0.318
His 0.146 0.164 0.173 0.175
Ile 0.438 0.447 0.474 0.476
Leu 0.547 0.575 0.630 0.63
Lys 0.538 0.566 0.566 0.567
Met 0.237 0.328 0.356 0.357
Phe 0.310 0.401 0.411 0.412
Pro 0.347 0.438 0.438 0.438
Ser 0.438 0.529 0.529 0.539
Thr 0.493 0.575 0.575 0.576
Trp 0.109 0.128 0.164 0.165
Tyr 0.255 0.347 0.319 0.32
Val 0.693 0.675 0.675 0.661
dATP 0.782 0.782 0.782 0.782
dTTP 0.782 0.782 0.782 0.782
dCTP 0.807 0.807 0.807 0.807
dGTP 0.807 0.807 0.807 0.807
ATP 0.807 0.807 0.807 0.807
UTP 0.665 0.665 0.665 0.665
CTP 0.616 0.616 0.616 0.616
GTP 0.992 0.992 0.992 0.992
a The following growth rates were determined when bacteria were cultured in the batch cultivation: BL21, 0.46 h-1; BL21/pOri1, 0.39 h-1; BL21/
pOri2, 0.29 h-1.Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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icant differences between plasmid-carrying E. coli and
plasmid-free E. coli. Table 7 shows the selected results of
DNA microarray experiments. In the carbon catabolism,
there were number of genes, which were up-regulated sig-
nificantly, suggesting that these groups of genes were
helpful for maintaining plasmid DNA in E. coli.
The expression levels of many carbon transport genes
were also affected in BL21/pOri2 and BL21/pOri1 com-
paring with BL21. Expression of genes involved in glucose
transport (ptsG) was increased significantly during the
early stationary phase and the same growth status.
Genes involved in glycolysis (fba, gapA, eno, pykF) were sig-
nificantly up-regulated in BL21/pOri2 and BL21/pOri1
relative to BL21, however the PP pathway genes (zwf and
gnd) were significantly down-regulated in early stationary
phase growing E. coli cells and at the same growth rate 0.2
h-1 (Table 7). pta and ackA, genes responsible for the ace-
tate metabolism [31,32], were upregulated in BL21/pOri1
and BL21/pOri2 strains (Table 7).
Most of the tricarboxylic acid cycle genes were up-regu-
lated (including: gltA, acnA, acnB, icdA, sucA, sucB, sucC,
sucD, sdhC, fumA, fumB, fumC) in BL21/pOri1 and BL21/
pOri2 strains relative to the plasmid-free strain (Table 7).
The glyoxylate shunt genes, aceB and aceK, showed down-
regulation in plasmid-bearing cells (Table 7). These
results correlate with the enhanced TCA cycle pathway
and an impaired glyoxylate pathway [33]. The sfcA and
maeB genes, which are known to be the main gluconeo-
genic pathway genes in E. coli, were also down-regulated.
Among the genes involved in the cellular structure, DNA
replication, transcription, and translation, only relatively
few genes were slightly up-regulated or down-regulated in
pleasmid-bearing cells.
Our results indicated that transcription of most of genes
did not change significantly in BL21/pOri1 relative to
BL21/pOri2. However, expression of the rpiA gene, encod-
ing RPI enzyme, was significantly decreased in BL21/
pOri2 relative to BL21/pOri1.
In summary, when considering enzyme activity analysis,
metabolic flux analysis and DNA microarray results, the
rpiA gene was selected as the key gene, which might affect
biology of ColE1-like plasmids.
Effects of the rpiA gene on ColE1-like plasmid copy 
number
To determine the role of the rpiA gene, a plasmid was con-
structed to overexpress this gene. This plasmid, pETrpiA,
was introduced into BL21/pOri2 and BL21/pOri1, and
two constructed strains BL21/pOri2/pETrpiA and BL21/
pOri1/pETrpiA were used for analysis of effects of rpiA
gene on the plasmid DNA copy number. During IPTG
induction, BL21, BL21/pOri1, BL21/pOri2, BL21/pOri1/
pETrpiA, BL21/pOri2/pETrpiA were cultured with the fol-
lowing growth rates: BL21, 0.46 h-1; BL21/pOri1,0.39 h-1;
BL21/pOri2, 0.29 h-1; BL21/pOri1/pETrpiA, 0.39 h-1; or
BL21/pOri2/pETrpiA, 0.29 h-1. Then, plasmid DNA copy
number of pOri2 and pOri1 were determined by the real-
time PCR method.
A significantly increased pOri2 and pOri1 plasmid DNA
copy number was found after induction of rpiA expression
with 1 mM IPTG for 1 h (Fig. 4). These results suggest that
in E. coli carrying a high copy number plasmid pOri2, the
RPI enzyme is deprived, which in turn causes a decrease of
Analysis of metabolic intermediates during cultivation of E.  coli BL21 (0.46 h-1), BL21/pOri1 (0.39 h-1) and BL21/pOri2  (0.29 h-1) at the early stationary phase in a chemostat-fer- mentor system (A), and cultivation of E. coli BL21 (0.2 h-1),  BL21/pOri1 (0.2 h-1) and BL21/pOri2 (0.2 h-1) at the same  growth rate (B) Figure 2
Analysis of metabolic intermediates during cultivation of E. 
coli BL21 (0.46 h-1), BL21/pOri1 (0.39 h-1) and BL21/pOri2 
(0.29 h-1) at the early stationary phase in a chemostat-fer-
mentor system (A), and cultivation of E. coli BL21 (0.2 h-1), 
BL21/pOri1 (0.2 h-1) and BL21/pOri2 (0.2 h-1) at the same 
growth rate (B).Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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the plasmid copy number. Thus, overproduction of RPI
significantly increased the plasmid DNA copy number in
E. coli.
Discussion
Plasmids, as non-essential DNA molecules, require addi-
tional intracellular materials and energy to exist in host
cell, thus usually reducing the growth rate of a bacterial
culture [8,27,34]. Plasmid DNA has been considered as a
molecular parasite [8] or a minimal genome [35]. How-
ever there is still a lack of a global analysis of the effects of
plasmid DNA on the metabolism of E. coli [6].
Cultivation conditions affect plasmid DNA content signif-
icantly [36,37]. Andersson et al. [38] used the batch cul-
ture to analyse the effect of plasmid DNA on the
Metabolic flux results of E. coli BL21, BL21/pOri1 and BL21/pOri2 in chemostat system with the early stationary phase BL21  (0.46 h-1), BL21/pOri1 (0.39 h-1) and BL21/pOri2 (0.29 h-1) (A), and with the growth rate as 0.2 h-1 (B) Figure 3
Metabolic flux results of E. coli BL21, BL21/pOri1 and BL21/pOri2 in chemostat system with the early stationary phase BL21 
(0.46 h-1), BL21/pOri1 (0.39 h-1) and BL21/pOri2 (0.29 h-1) (A), and with the growth rate of 0.2 h-1 (B). The flux results (BL21: 
Up; BL21/pOri1: Middle; BL21/pOri2: Down) are shown in panels A and B. Abbreviations: Glc: glucose; G6P, glucose-6-phos-
phate; F6P, fructose-6-phosphate; F16P, Fructose-1,6-bisphosphat; G3P, Glyceraldehyde-3-phosphate; PGP, 1–3-diphos-
phoglycerate; 3PG, 3-Phosphoglycerate; 2PG, 2-Phosphoglycerate PEP, phosphoenolpyruvate; Pyr, pyruvate; 6PGlac, 6-
Phospho-Gluconolactone; 6PG, 6-Phospho-Gluconate; Ru5P, ribulose-5-phosphate; X5P, xylulose-5-phosphate; R5P, ribose-5-
phosphate; S7P, sedoheptulose-7-phosphate; E4P, Erythrose 4-phosphate; AcCoA, Acetyl coenzyme A; AcP, Acetyl-P; Ac, ace-
tate; Cit, Citrate; ICit, Iso-Citrate; α-KG, α-ketoglutarate; SuccCoA, Succinyl-Coenzym-A; Succ, succinate; Fum, fumarate; Mal, 
malate; OxA oxaloacetate.Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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metabolism of E. coli, and Klemperer et al. [39] analysed
the requirements of minimal nutritional conditions of E.
coli in batch culture with or without plasmid DNA. How-
ever, in the batch cultivation, plasmid DNA content might
be significantly different between different growth status.
Therefore, on the basis of those studies, it is difficult to
analyse the effects of plasmid DNA on the metabolism of
E. coli. We considered that the use of chemostat cultiva-
tion system is appropriate for plasmid DNA metabolism
analysis.
A direct comparison between plasmid-bearing and plas-
mid-free E. coli may be inappropriate to find the meta-
bolic limiting factors of plasmid DNA replication [8].
Rozkov et al. [6] have found that significant differences
between a plasmid-free E. coli and the same host bearing
a plasmid were due to expression of the kanamycin phos-
photransferase gene (used as a plasmid marker). Thus, it
appears that to analyse the metabolic limiting factors of
plasmid copy number, a comparison of plasmid-contain-
ing with plasmid-free cells may be inaccurate.
Another methodological problem arises from the finding
that growth rates affect the cell biomass significantly [40],
and biomass ingredients have direct effects on the meta-
bolic flux [41]. The presence of plasmids has significant
effects on the ingredient of biomass, thus it is not reason-
able to assume that the biomass is constant, which makes
problems in interpretation of results to analyse the effects
of plasmids on the metabolism of host cells.
To avoid all these problems, we constructed two different
plasmids, derived from ColE1. The first plasmid (pOri1)
contains one ColE1 replication origin, and the second
plasmid (pOri2) contains two ColE1 plasmid DNA repli-
cation origins. Moreover, we used a stable culture status to
analyse the effects of plasmid DNA on the metabolism of
E. coli. Plasmid DNA copy number was significantly
Table 7: DNA microarray analysis of expression of selected genes in E. coli BL21, BL21/pOri1 BL21/pOri2 grown in the chemostat 
system at different growth rates.
Gene Ratio of gene transcriptsa
ABCD
rpiA 0.59 0.03 0.45 0.04
tktB 0.11 0.13 0.07 0.19
sfcA 0.25 0.24 0.19 0.21
gnd 0.30 0.31 0.26 0.48
maeB 0.31 0.30 0.26 0.47
talB 0.31 0.32 0.35 0.40
rpe 0.41 0.40 0.42 0.62
zwf 0.50 0.52 0.59 0.55
aceB 0.51 0.48 0.55 0.69
aceK 0.63 0.61 0.51 0.92
tktA 0.61 0.63 0.55 0.99
sucD 2.80 3.10 2.01 3.25
pykF 2.80 3.10 1.83 3.17
sdhC 2.90 3.50 3.19 4.66
eno 2.90 2.50 3.02 3.47
sucC 3.02 3.12 3.25 3.41
pta 3.00 3.60 3.34 5.11
sucB 3.10 3.40 3.59 3.10
icdA 3.20 5.10 2.45 6.23
gltA 3.20 4.10 3.62 5.60
gapA 3.60 4.10 4.01 6.19
fbaA 3.60 3.80 2.38 5.41
acnB 3.60 4.60 3.80 4.36
sucA 3.60 3.90 3.93 3.76
ptsG 3.80 4.10 4.48 6.50
ackA 4.80 5.40 4.83 7.92
fumB 4.90 5.10 3.45 8.08
fumA 5.20 6.40 5.83 9.30
acnA 5.90 6.70 6.77 9.96
fumC 6.60 6.50 4.38 10.30
a The results are average values from 4 experiments. Abbreviations: A, ratio of BL21/pOri1 (μ = 0.39) to BL21 (μ = 0.46); B, ratio of BL21/pOri2 (μ 
= 0.29) to BL21 (μ = 0.46); C, ratio of BL21/pOri1 (μ = 0.20) to BL21 (μ = 0.20); D, ratio of BL21/pOri2 (μ = 0.20) to BL21 (μ = 0.20).Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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increased when two origin regions were present. We
assumed that comparison of BL21/pOri1 and BL21/pOri2
should be accurate to analyse the effects of plasmid DNA
on the metabolism of E. coli. Moreover, we have used the
13C-labelling experiments, DNA microarray and enzyme
activity analysis to explore the metabolic differences. The
13C-labelling experimental results provided a large body
of data to calculate the intracellular fluxes, and the iso-
topic enrichment in the intracellular metabolite pools.
This technique, in a combination with DNA microarray
and enzyme activity analysis, is a powerful method for
screening of metabolic nodes or bottlenecks for plasmid
DNA metabolism.
In our experiments, during early stationary phase, ColE1-
derived plasmids pOri1 and pOri2 have significant effects
on the metabolism of E. coli. TCA cycle, respiration rate
and acetate yield were significantly increased in BL21/
pOri1 and BL21/pOri2 strains. Also, the PP pathway flux
was significantly decreased, and the ATP expenditure was
increased in BL21/pOri2 significantly more than in BL21/
pOri1. These results suggest potential sources of meta-
bolic burden during plasmid DNA replication in the early
stationary phase.
In experiments with the controlled cultivation growth rate
at 0.2 h-1, the effects of ColE1-like plasmids pOri1 and
pOri2 on the E. coli BL21 metabolism were significantly
different relative to experimental results obtained from
the experiments with early stationary phase. Our results
show that PP pathway flux was generally increased, except
the flux from Ru5P to R5P, in BL21/pOri2 relative to
BL21/pOri1. From the metabolic flux analytical results
obtained from the cultivation at the early stationary phase
and at the same growth rate, we conclude that the flux
from Ru5P to R5P is important for plasmid DNA replica-
tion, while TCA cycle, ATP or glucose uptake are not the
limiting factors. To confirm these results, we performed
enzyme activity analysis and mRNA expression profiles
analysis.
Plasmid pOri1 and pOri2 copy number in BL21, with or without the presence of pETrpiA plasmid, uninduced (■) or induced  () wiith IPTG Figure 4
Plasmid pOri1 and pOri2 copy number in BL21, with or without the presence of pETrpiA plasmid, uninduced (■) or induced 
() wiith IPTG. Plasmid copy number was determined using a real-time PCR method.Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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The enzyme activity analysis was performed in bacterial
cultures kept in the early stationary phase and the same
growth rate. The glycolysis enzyme activities and most
TCA enzyme activities were increased in BL21/pOri1 and
BL21/pOri2 relative to BL21, while the enzyme activities
of the PP pathway were significantly decreased. Moreover,
the RPI enzyme activity was decreased significantly.
The gene expression profiles, obtained from DNA micro-
array experiments, were consistent with the results for
early stationary phase and at the same growth rate. The
gene expression profiles for BL21/pOri1, BL21/pOri2 and
plasmid-free cells agree with the enzyme activity analysis.
In BL21/pOri2 cultures, the phosphotransferase system
for glucose uptake and glycolytic genes were up-regulated
in comparison to those in BL21 cultures. On the other
hand, genes involved in acetate secretion and the TCA
cycle were up-regulated in BL21/pOri2 and BL21/pOri1,
whereas the genes involved in the glyoxylate cycle and glu-
coneogenesis were down-regulated. The most striking dif-
ference between BL21/pOri2 and BL21/pOri1 was the
regulation of PP pathway genes. These genes are either
essential or carry significant metabolic flux for nucle-
otides' synthesis. Expression of the rpiA gene was signifi-
cantly decreased in BL21/pOri2. From the metabolic flux
analysis, enzyme activity analysis and mRNA expression
profiles, we concluded that the rpiA gene is one of the
important limiting factors for plasmid DNA replication.
The PP pathway has fewer enzymes than glycolysis, how-
ever, this pathway is more complicated [42]. It is involved
in the generation of NADPH for biosynthesis, recruiting
essential metabolites for nucleic acids, amino acids and
vitamins, and the generation of ingredients of the cell
lipopolysaccharide layer [43]. Amino acids and nucle-
otides are important for plasmid DNA replication. More-
over, during plasmid DNA replication, especially when a
plasmid occurs at high copy number, an extra synthesis of
nucleotides is needed. Thus, it is possible that the carbon
flux, which is driven through the oxidative branch of the
PP pathway, is not enough to handle the cell metabolic
needs [44], particularly when the growth rate is decreased.
Furthermore, the PP pathway is the only pathway that
allows E. coli to use some sugars, such as D-xylose, D-
ribose, or L-arabinose [45,46].
RPI is the enzyme that converts Ru5P into R5P, and this
enzyme activity decreases the flux into X5P. This flux is
not redirected into the Embden-Meyerhof (EM) pathway,
and a large part of the flux into Ru5P is used for synthesis
of nucleotides. RPI plays a key role in ribose 5-phosphate
metabolism [47]. E. coli has two recognisable ribose-5-
phosphate isomerase: a constitutive ribose-5-phosphate
isomerase A and an inducible ribose-5-phosphate isomer-
ase B, the latter being present in distinguishable amounts
only when cells grow on D-ribose or ribose-5-P-delivering
compounds, such as adenosine or uridine, as the sole car-
bon source [45,46,48]. It has been demonstrated that ade-
nosine and uridine can be used to increase plamsid DNA
copy number [44]. Thus, we suppose that inducible
ribose-5-phosphate isomerase B can be used to increase
ColE1-like plasmid DNA copy number. Although ribose-
5-phosphate isomerase A could not be induced by D-
ribose or ribose-5-P-delivering compounds, an expression
of the gene coding for ribose-5-phosphate isomerase A,
using a plasmid system, should lead to a significant
increase in the total activity of this enzyme in the cell. In
fact, Hove-Jensen and Maigaard found that a plasmid con-
taining the rpiA  gene can significantly (about 40-fold)
increase the ribose-5-phosphate isomerase A activity in E.
coli [47]. These results show that the ribose-5-phosphate
isomerase A activity can be increased when the protein
overproduction system is employed. Although Hove-
Jensen and Maigaard did not analyze the effects of ribose-
5-phosphate isomerase A activity on plasmid DNA repli-
cation [47], here, we found that the overproduced ribose-
5-phosphate isomerase A can cause a significant increase
in the ColE1 plasmid DNA copy number.
Considering all the data mentioned above, we have tested
ColE1-like plasmid DNA copy number in E. coli cells over-
producing the ribose-5-phosphate isomerase A. In these
cells, copy number of plasmids pOri1 and pOri2 was sig-
nificantly increased, indicating that RPI may be a limiting
factor for ColE1-like plasmid DNA replication, indeed.
Our results have also potential biotechnological applica-
tions. Namely, modification of the PP pathway by
enhancement of the rpiA gene expression can significantly
increase ColE1-like plasmid DNA copy number in E. coli.
In the light of the role of plasmids in gene therapy and
development of DNA vaccines, such improvement may be
considerable. Increased plasmid copy number may also
lead to more effective expression of recombinant genes
coding for desrired proteins. In fact, it was demonstrated
previously that the PP pathway has an important limita-
tion in the metabolism of E. coli [49], namely, the growth
rate and recombinant protein expression were increased
in  E. coli cells overproducing the glucose-6-phosphate
dehydrogenase.
Materials and methods
Bacterial strains, plasmid construction and cultivation 
conditions
E. coli strain BL21(DE3) (Invitrogen, CA) and ColE1-
derived plasmids pOri1, pOri2 were used. Fig. 1 shows the
constructions of pOri1 and pOri2. pOri1 plasmid con-
tains a single ColE1 replication origin and an ampicillin-
resistance gene, while pOri2 plasmid contains two ColE1
replication origins and an ampicillin-resistance gene. TheMicrobial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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designed forward primer: 5' GCA ATC CAA ATG GGA TTG
CTA GGA 3' and reverse primer: 5' CAT CGG TAT CAT
TAC CCC ATG AAC 3' were used to amplify the replica-
tion origin of ColE1 plasmid [GenBank:NC001371] with
AccuPrime Pfx DNA polymerase (Invitrogen, CA). The fol-
lowing two-step PCR reactions were performed: one cycle
at 95°C for 2 min, 35 cycles at 95°C for 15 s, 68°C for 1
min. Finally, PCR products were kept at 4°C after cycling.
Another PCR reaction was used to amplify an ampicillin-
resistance gene from pUC18 plasmid (Invitrogen, CA)
with the forward primer: 5' GAG TAA ACT TGG TCT GAC
AGT 3' and reverse primer: 5' GGT TAA TGT CAT GAT AAT
AAT 3'. The blunt-end PCR product of ColE1 replication
origin region was linked with 5' phosphorylated blunt-
end PCR product of an ampicillin-resistance gene to con-
struct plasmid pOri1. Orientation of the insert was con-
firmed by DNA sequencing. Another PCR reaction was
performed using the forward primer: 5' GCA ATC CAA
ATG GGA TTG CTA GGA 3', and reverse primer: 5' GGT
TAA TGT CAT GAT AAT AAT 3' to amplify the whole pOri1
plasmid with AccuPrime Pfx DNA polymerase. The ampli-
fied PCR product was linked with 5' phosphorylated PCR
product of the ColE1 replication origin fragment to con-
struct plasmid pOri2. Thus, plasmid pOri2 contains two
ColE1 replication origins. Both pOri1 (2,811 bp) and
pOri2 (4,575 bp) were used to transform BL21 cells.
Single clones were selected from the LB plates containing
100 μg ml-1ampicillin, and cultured in LB medium for 12
h. Then 5 ml culture broth was inoculated into 125 ml of
a fresh LB medium including 100 μg ml-1ampicillin for
another 10–15 h. Finally, E. coli cells were washed with
sterilized PBS buffer (phosphate buffered saline, pH7.2)
before inoculation into the fermentor.
All cultures were carried out in a 5 l fermentor BIOSTAT B-
DCU (Sartorius BBI Systems Inc. Melsungen) at control-
led temperature 37°C, pH 7.0, and dissolved oxygen ten-
sion 30%. The culture volume was 2 l. All reagents were
purchased from Sigma-Aldrich, Inc. The synthetic culture
medium consisted of (values in g l-1): 8, glucose; 14.6,
K2HPO4; 3.6, NaH2PO4  · H2O; 2.68, (NH4)2SO4; 2,
Na2SO4; 1, MgSO4; 1, Na-citrate; 0.5, NH4Cl; 2 ml of 10
mg l-1 of thiamine; and 3 ml of trace element solution (in
g l-1): 20.0, Na-EDTA; 15.0, FeCl3 · 6H2O; 0.5, CaCl2 ·
2H2O; 0.2, ZnSO4  · 7H2O; 0.2, CoCl2  · 6H2O; 0.2,
CuSO4 · 5H2O; 0.2, MnSO4 · 4H2O. The chemostat cul-
ture was performed by addition of feed medium (the com-
position was the same as the culture medium). The
continuous culture reached steady state growth after five
residence times with the specific growth rate; no signifi-
cant plasmid DNA lose (as estimated by determining a
fraction of amplicillin-resistant bacteria) was found dur-
ing the cultivation. Labelling experiments were started
after the chemostat culture reached a steady state, then the
feed medium containing 8 g l-1 of unlabelled glucose was
replaced with the medium containing 1.8 g l-1 [U-13C]glu-
cose and 6.2 g l-1 of natural glucose, or 8 g l-1of [1-13C] glu-
cose. The samples were collected after one residence time
when the substrate was changed to the labelled glucose.
Determination of bacterial ingredients
DNA content was measured by the diphenylamine rea-
gent method with calf thymus DNA as a standard [50].
Amounts of genomic DNA were obtained by subtracting
plasmid DNA from total DNA amount. RNA level was
determined by the Schmidt-Tannhauser method [51].
For the analysis of free amino acids, freeze-dried biomass
was suspended in distilled water. The biomass was boiled
in water for 15 min. The suspension was centrifuged at
10,000 g  for 10 min, and the free amino acids in the
supernatant were analysed using high-performance liquid
chromatography (HPLC) series 200 LC Plus UV/Vis Sys-
tem (PerkinElmer, MA). The total pool of amino acids was
analysed by HPLC after E. coli samples were hydrolyzed
with 6 M HCl for 24 h at 110°C. Values for amino acids
derived from proteins were obtained by subtracting the
values of free amino acid from the total amino acid
amout.
For the analysis of total nitrogen content in E. coli, sam-
ples were hydrolyzed with 6 M HCl for 24 h at 110°C. The
nitrogen content originating from protein in E. coli was
calculated using the method of subtracting the nitrogen
contents in RNA, DNA, and free amino acids from the
total nitrogen content measured by the Kjeldahl method
[52]. The protein content was determined according to
nitrogen content originating from proteins in E. coli. Lip-
ids were extracted with chloroform and methanol. The
lipid content was determined by gas chromatography
(GC) analysis with Clarus 500 Gas Chromatograph (Perk-
inElmer, MA) [53]. Glycogen contant was determined by
the method described by Dauvillee et al. [54], peptidogly-
can was determined by the method described by Chan-
drakala et al. [55] and LPS was determined by the method
described by Boman and Monner [56].
Analysis of growth and enzyme activity
Dry cellular weight (DCW) from the cultures was moni-
tored by optical density at 600 nm (OD600) and converted
to DCW based on the determined OD-to-DCW correla-
tions. Glucose concentration was determined using glu-
cose assay kit (Sigma). Acetate concentrations in the
culture broth were measured by HPLC. CO2 production
and O2 consumption were measured by passing the out-
going gas from the fermentor through a Servomex CO2
and O2 analysers (Servomex Company Inc. TX), respec-
tively [57]. Specific enzymes, which are located at the
main branch points of the central metabolic pathways,Microbial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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were analyzed in crude cell extracts from E. coli BL21,
BL21/pOri1 or BL21/pOri2. Enzyme activity was
expressed as the amount of enzyme required to convert 1
μmol substrate into specific product per minute per milli-
gram of protein. E. coli cells were harvested from 500 ml
culture broth by centrifugation at 10,000 g for 10 min,
washed twice with TE buffer (100 mM Tris-HCl, pH 7.0,
0.1 mM EDTA), then resuspended in 50 ml of TE buffer
and disrupted in an ultrasonicator. The cellular debris was
removed by centrifugation, and the resulting crude cell
extracts were immediately used for determination of spe-
cific enzyme activities or stored at -70°C. Protein concen-
trations were estimated using a QuantiPro high sensitivity
protein assay kit (Sigma). Enzyme activities were meas-
ured spectrophotometrically at 37°C in a DU Series 500
UV/Vis Spectrophotometer (Beckman, CA). Reaction mix-
ture and substrate were added into a cuvette with a 1 cm
light path, and reactions were initiated by adding the cell
extract or substrate to give the final volume of 1 ml. The
same amount of protein was added to compare the
enzyme activities of different samples, and each measure-
ment was performed in triplicate. Activities of all selected
enzymes were measured using the already published
methods, as follows: Hexokinase (HEK) (EC 2.7.1.1) [58];
Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) [59];
6-phosphofructosekinase (PFK) (EC 2.7.1.11) [60]; Fruc-
tose-1,6-bisphosphatase (FBP) (EC 4.1.2.13) [60]; Fruc-
tose-bisphosphate aldolase (FBA) (EC 4.1.2.13) [58];
Glyceraldehyde-3-phosphate dehydrogenase (GPD) (EC
1.2.1.12) [61]; Triose phosphate isomerase (TPI) (EC
5.3.1.1) [62]; Phosphoenolpyruvate carboxylase (PPC)
(EC 4.1.1.31) [63]; Pyruvate kinase (PK) (EC 2.7.1.40)
[62]; Glucose-6-phosphate dehydrogenase (GPDH) (EC
1.1.1.49) [61]; 6-Phosphogluconolactonase (PGL) (EC
3.1.1.31) [64]; Phosphogluconate dehydrogenase (PGD)
(EC 1.1.1.44) [61]; Ribulose-phosphate 3-epimerase
(RPE) (EC 5.1.3.1) [65]; Ribose-5-phosphate isomerase
(RPI) (EC 5.3.1.6) [47]; Transketolase (TK) (EC 2.2.1.1)
[66]; Transaldolase (TA) (EC 2.2.1.2) [67]; Citrate syn-
thase (CS) (EC 2.3.3.1) [68]; NADP+-specific isocitrate
dehydrogenase (ICD) (EC 1.1.1.42) [69]; Isocitrate lyase
(ICL) (EC 4.1.3.1) [63]; Aconitate hydratase (AH) (EC
4.2.1.3) [70]; Oxoglutarate dehydrogenase (OGD) (EC
1.2.4.2) [71]; Succinic semialdehyde dehydrogenase (SD)
(EC 1.2.1.16) [63]; Fumarate hydratase (FH) (EC 4.2.1.2)
[72]; Malate dehydrogenase (MD) (EC 1.1.1.37) [73];
Malic enzyme (MAC) (EC 1.1.1.40) [63]; Phosphoe-
nolpyruvate carboxykinase (PCK) (EC 4.1.1.38) [63].
Analysis of plasmid DNA copy number with real-time PCR 
method
109 E. coli cells were harvested from the culture broth, and
the pellets were resuspended with 250 μl TGE buffer (1M
Tris-HCl, pH 8.0; 50 mM, glucose; 0.5 M EDTA, pH 8.0).
Then, 250 μl of SDS-NaOH lysis buffer (0.2 M NaOH; 1%
SDS) and 350 μl of 3 M potassium acetate (adjusted to pH
4.8 with acetic acid) were added. After incubated on ice
for 10 min, the mixture was centrifuged at 12,000 g for 10
min, and the finial supernatants were used for real-time
PCR analysis of the plasmid DNA concentration.
QuantiTect SYBR Green PCR kit (Qiagen) was used for
determination of plasmid DNA concentration. The for-
ward primer: 5' ATG AGT ATT CAA CAT TTC CGT GTC 3'
and reverse primer: 5' CTT CCG GCT GGC TGG TTT ATT
GCT 3' were used to amplify an ampicillin-resistance gene
in pOri1 or pOri2 plasmid. The PCR reactions were per-
formed in iQ5 real-time PCR detection system (Bio-rad,
CA). The serial dilutions of pOri1 or pOri2 plasmid DNA
solutions were used as standards for determination of
plasmid DNA concentration in the cellular lysate.
Plasmid DNA copy number was determined employing
the following equation: 6.02 × 1023 × (C × V)/(N × M × 2
× BP), where C is the plasmid DNA concentration in the
lyaste; V is the volume of cleared lysate; N is the total E.
coli cell number for plasmid copy number determination,
M is the formula 'molecular' weight of plasmid DNA,
which was determined as described previously [44]. BP is
the number of base pairs in plasmid DNA.
Metabolic flux analysis with 13C-labeled glucose
To obtain 13C-labeled amino acids from a biomass, 2 ml
of bacterial culture were harvested and centrifuged at
12,000 g, 4°C for 2 min. Cell pellets were washed with 20
mM Tris · HCl (pH 7.6) and hydrolyzed in 0.5 ml of 6 M
HCl at 105°C for 24 h. Following liofilization drying the
sample under vacuum, it was suspended in 1 ml of anhy-
drous ethanol. Then, the ethanol was evaporated in a vac-
uum at room temperature. 100 μl of acetonitrile and 100
μl of N-methyl-N-(tert-butyldimethylsilyl)trifluoroaceta-
mide (MTBSTFA) were added to the dried sample. The
reaction mixture was heated at 70°C for 30 min. After
cooling to room temperature, the suspension was filtered
through cotton. This solution was directly injected onto
the GC column. The derived amino acids were firstly sep-
arated by the GC, then ionized, and subsequently frag-
mented in the MS. The fragments contained different
subsets of the original carbon skeleton. The most com-
mon MS fragments of the N(O)-tert-butyldimethylsilyl
amino acids were as follows: [M – 15]+ (loss of CH3); [M
– 57]+ (loss of C(CH3)3); [M – 85]+ (loss of C(CH3)3-CO);
[M – 131]+ (loss of OtBDMS); [M – 159]+ (loss of COOt-
BDMS). The labelling patterns of free intracellular amino
acids of E. coli were analysed by Clarus 500 GC mass spec-
trometer (PerkinElmer, MA).
For metabolic flux ratio analysis, mass spectra of the deri-
vatized amino acids were corrected for the natural abun-
dance of all stable isotopes. The metabolic flux ratioMicrobial Cell Factories 2006, 5:34 http://www.microbialcellfactories.com/content/5/1/34
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analysis was performed using the FiatFlux 1.0 software
[25].
After determination of the metabolic flux ratio of E. coli
with FiatFlux 1.0 RATIO package, the metabolic fluxes of
E. coli were determined with FluxAnalyzer 5.1 software
[26]. The reaction equations were designed according to
the metabolic equations of E. coli, published previously
[74]. The biomass was determined separately as protein,
lipid, RNA, genomic DNA and plasmid DNA, LPS, pepti-
doglycan, and glycogen. The mathematical framework for
flux estimation was predicted based on an initial set of
fluxes, then calculated fluxes were compared with the
measured values. This iterative procedure continued until
the error between the calculated and measured values was
below the set criterion (varying measurement and calcula-
tion was set as 0.01 for each reaction) with simple least
squares methods.
Transcriptome analysis
E. coli samples for RNA extraction were taken during fer-
mentation. Cells were harvested by centrifugation at the
cultivation temperature (37°C, 10,000 g, 1 min), sepa-
rated from the supernatant, and rapidly frozen in dry ice.
The samples were stored at -70°C until analysis. Gene-
Chip E. coli Antisense Genome Array (Affymetrix, USA)
chips were used for DNA microarray analysis. The array
included more than 4,200 genes from E. coli K12. For tran-
scriptome analysis, 15 μg of RNA from each sample was
reverse-transcribed into cDNA with random primers.
GeneChip DNA labelling reagent (Affymetrix, USA) was
used to label the 3' ends of cDNA products. Finally, the
labelled cDNA samples were hybridized to the cDNA
array. Scanning was performed with a DNA Microarray
Scanner BA (Agilent Technologies, Inc, CA).
Cloning the rpiA gene from E. coli BL21
E. coli K12 genomic sequence [GenBank:NC000913] was
used to design the primers, and the designed forward
primer: 5' GGG GGA TCC GGA TGG GCG GCA CTT CAG
TAT GTT 3' and reverse primer: 5' GGG CTC GAG TTA TTT
CAC AAT GGT TTT GAC ACC GTC 3' were used for PCR
reaction. The forward primer contains BamHI cloning site,
and the reverse primer contains the XhoI cloning site
(underlined). PCR reaction was used to amplify the rpiA
gene from BL21 genomic DNA. The amplified PCR prod-
uct was digested with BamHI and XhoI, respectively. The
digested PCR products were inserted into the BamHI- and
XhoI-digested pET28a vector (bearing the pMB1 replica-
tion origin) by T4 DNA ligase. Finally, the ligation product
was used to transform E. coli DH5α competent cells. Then,
the clones were selected, and the constructed plamid
pETrpiA was used to transform BL21, BL21/pOri1, and
BL21/pOri2 strains.
To analyse the effects of pETrpiA on the plasmid pOri1 or
pOri2 copy number in BL21, BL21/pOri1/pETrpiA, BL21/
pOri2/pETrpiA, bacteria were cultured in 125 ml LB
medium containing 100 μg ml-1 ampicillin and 50 μg ml-
1 kanamycin. Before the E. coli cells were inoculated into 5
l fermentor with the working volume of 2 l, E. coli cells
were washed with sterilized PBS buffer, then the synthetic
culture medium was used for chemostat cultivation in 5 l
fermentor. During the early stationary phase, BL21, BL21/
pOri1/pETrpiA or BL21/pOri2/pETrpiA was induced with
1 mM IPTG. The final growth characteristics were ana-
lyzed.
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